ENSGEnsign Group, Inc.
Ensign Group, Inc. (ENSG) operates skilled nursing facilities and provides post-acute care services, with a focus on long-term care for Medicare beneficiaries. The next catalyst is Oct 26, 2026 — Q4 2026 Earnings Release, which will test the business’s ability to sustain revenue growth and margin expansion amid rising costs and regulatory headwinds.
- Revenue grew 18.8% YoY to $5.33B in 2026, driven by new facility acquisitions and improved occupancy.
- Free cash flow reached $839.14M in the trailing twelve months, with a net margin of 7.2% and a debt-to-equity ratio of 0.07x.
- The company’s balance sheet remains strong, with $2.23B in shareholders’ equity, but its ability to maintain margins amid inflation and reimbursement pressures will be key.
The Read
ENSG's stock historically showed a median absolute move of ~12%.
The schedule
- Mon26Oct
This earnings release will test the company's ability to maintain its momentum and deliver on its guidance. The outcome will be crucial for assessing the company's ability to sustain its current valuation and meet investor expectations.
- Tue15Dec
This event will test the company's ability to execute on its acquisition strategy and generate value for shareholders. The outcome will be crucial for assessing the company's ability to sustain its current valuation and meet investor expectations.
- Thu29Apr
This earnings release will test the company's ability to maintain its momentum and deliver on its guidance. The outcome will be crucial for assessing the company's ability to sustain its current valuation and meet investor expectations.
- Fri23Jul
This earnings release will test the company's ability to maintain its momentum and deliver on its guidance. The outcome will be crucial for assessing the company's ability to sustain its current valuation and meet investor expectations.
Past
- Tue1Sep
Actual outcome: Bear · $172.84 at outcome
The stock closed at $172.84 on the outcome date, which is above the bear floor of $170.00, but the price reaction from the event date to the outcome date was flat. The CMS reimbursement updates did not provide enough positive momentum to push the stock above the bull target of $190.00. The lack of significant movement suggests the market was uncertain about the long-term impact of the updates, particularly given the ongoing legal investigations, which overshadowed any potential positive outcomes.
The key CMS reimbursement updates for skilled nursing facilities are an important event that could impact the stock's performance. These updates may influence sector performance and company valuation, especially given the company's exposure to this area. Positive reimbursement updates could lead to a price increase, especially if they reflect favorable changes that benefit the company. However, there is also the potential for uncertainty due to ongoing legal investigations, which could affect the outcome.
- Thu30Jul
This earnings release will test the company's ability to maintain strong EPS growth and manage its cash flow amid macroeconomic uncertainty. The outcome will be critical for assessing the company's operational performance and its ability to sustain its current valuation.
- Thu30Apr
Actual outcome: Bear · $178.00 at outcome
Ensign Group reported Q1 earnings that met EPS estimates and raised its full-year 2026 earnings and revenue guidance, bolstered by occupancy gains and new facility acquisitions. However, the market focused on higher operating costs and a slight revenue miss that tempered the results. Consequently, the stock sold off, falling 4.7% by the outcome date and eventually breaking below the bear floor.
- Wed4Feb
Actual outcome: Bull · $203.93 at outcome
The catalyst resulted in a mixed outcome as the stock remained flat, failing to hit either target despite the company missing Q4 EPS estimates ($1.61 actual vs. $1.75 consensus). The lack of negative movement suggests the market overlooked the miss, likely due to strong FY2026 guidance and consistent acquisition-fueled growth. This operational expansion was highlighted by the recent purchases of operations and real estate in Wisconsin, Texas, and Arizona, providing confidence that the company's long-term growth trajectory remains intact.
